Market Place
Sourcing Support
LivaNova CORE-VNS Data Show Big Seizure Drop at 24 Months
05 Jun 2025 //
BUSINESSWIRE
LivaNova Seeks CMS Reconsideration for VNS Therapy in Depression
04 Jun 2025 //
BUSINESSWIRE
LivaNova to Present at the Jefferies Global Healthcare Conference
15 May 2025 //
BUSINESSWIRE
LivaNova Announces 12-month Data from OSPREY Study on Sleep Apnea
07 May 2025 //
BUSINESSWIRE
LivaNova Updates On RECOVER VNS Therapy Depression Study
07 Jun 2024 //
BUSINESSWIRE
LivaNova Provides Update On RECOVER VNS Therapy Depression Study
06 Jun 2024 //
BUSINESSWIRE
LivaNova Announces a Positive Outcome of Trial of OSPREY for Sleep Apnea
20 Mar 2024 //
BUSINESSWIRE
LivaNova offers fix for recalled life support pump controllers
30 Jan 2023 //
FIERCE BIOTECH
FDA classifies recall of LivaNova`s blood-pumping system controller as most serious
27 Jan 2023 //
REUTERS
LivaNova and Verily Announce First Patient Enrolled in Study to Effectiveness
26 Apr 2021 //
BUSINESSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.